Teligent Lender Slams Creditor Group Bid To Claw Back Cash
By Jeannie O'Sullivan · February 8, 2022, 3:00 PM EST
A lender for bankrupt generic pharmaceutical company Teligent Inc. slammed a bid by unsecured creditors for derivative standing to claw back a $10 million reserve fund, insisting the debtor didn't incur...
To view the full article, register now.